P3 Health Partners Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- P3 Health Partners Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $43.22M, a 420.64% increase year-over-year.
- P3 Health Partners Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $8.30M, a 26.25% increase year-over-year.
- P3 Health Partners Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $13.99M.
- P3 Health Partners Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was -$24.00K.
- P3 Health Partners Inc. stock issued during period, value, new issues for fiscal 2024 was $8.47M, a 90.22% decline from fiscal 2023.
- P3 Health Partners Inc. stock issued during period, value, new issues for fiscal 2023 was $86.58M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $43.22M 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $8.30M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $13.99M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $8.47M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$24.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $6.58M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $86.58M 10-K · filed 2025-03-28 | |
| 2023-06-30 | $86.58M 10-Q · filed 2024-11-12 | |
| 2021-03-31 | $298.80M 10-Q · filed 2021-08-20 |